Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
News
24 May 2023
As part of a new Asia-Pacific (APAC) Life Sciences and Health Care webinar program designed both for companies with commercial interests in APAC and for companies based in the region, Hogan ...
Insights and Analysis
18 May 2023
On March 31, 2023, the Center for Drug Evaluation under the PRC National Medical Products Administration issued the Work Specification for Accelerating the Review of Innovative Drug...
News
17 May 2023
Publication of the French decree regarding the experimentation of the "direct access" to pharmaceutical products with anticipated reimbursement: a half-hearted step forward for...
News
04 May 2023
The U.S. Food and Drug Administration (FDA) has just published a highly-anticipated draft guidance on the implementation of decentralized clinical trials (DCTs) for drugs, biologics, and...
Insights and Analysis
28 April 2023
In this Q2/23 issue of our Life Sciences and Health Care Law Update, our teams highlight key developments across life sciences regulatory, compliance, competition, and privacy throughout...
News
28 March 2023
On March 10, 2023, the U.S. Food and Drug Administration (FDA) issued a Notice summarizing which of the agency’s COVID-19-related guidance documents will be rescinded and which will...
News
27 March 2023
While the French Data Protection Authority (the "CNIL") has consistently emphasized the importance of protecting health data, there will be even more focus for 2023 with more...
News
17 March 2023
On March 15, 2023, the Centers for Medicare & Medicaid Services (CMS) issued initial guidance on the Drug Price Negotiation Program, which was established under the Inflation Reduction...
News
14 March 2023
In the latest edition of our False Claims Act Guide: 2022 and the road ahead, we analyze the key developments from 2022 and discuss how the most important cases and issues are shaping FCA...
